New Zealand markets open in 6 hours 24 minutes

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
582.08-1.96 (-0.34%)
As of 09:36AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close584.04
Bid583.33 x 800
Ask584.00 x 1200
Day's range581.23 - 586.29
52-week range309.20 - 629.97
Avg. volume3,287,271
Market cap552.573B
Beta (5Y monthly)0.33
PE ratio (TTM)104.88
EPS (TTM)5.55
Earnings date06 Feb 2024
Forward dividend & yield4.52 (0.77%)
Ex-dividend date14 Nov 2023
1y target est630.67
  • Motley Fool

    1 Monster Dividend Stock Growth Investors Should Load Up On Right Now

    Dividend stocks have a well-earned reputation for outperformance. Modern portfolio theory (MPT), however, indicates that growth investors should strictly adhere to a couple of critical guidelines when picking dividend stocks for their portfolios. Among the most important guideposts recommended by the peer-reviewed MPT literature are selecting stocks with dividends lower than the average of the benchmark S&P 500 index; selecting stocks with premium valuations and a track record of positive annual returns; and selecting stocks in fast-growing sectors like healthcare or technology.

  • Simply Wall St.

    Is Eli Lilly and Company's (NYSE:LLY) 44% ROE Better Than Average?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • Reuters

    Eli Lilly again extends tender offer to buy Point Biopharma on low participation

    Lilly set Dec. 15 as the deadline in a third extension. The Indianapolis-based drugmaker maintained its offer price at $12.50 per share, which is over 10% lower than Point Biopharma's last closing price of $13.80. Lilly had struck a $1.4 billion deal to buy Point Biopharma in October.